Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The company announced its successful approval by the FDA for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (...
read more
LOTTE BIOLOGICS announced that it has signed a manufacturing agreement with an Asia-based biotech company for the production of a clinical-stage ADC candidate.
read more
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, announced that March Biosciences has been awarded a $200,000 G-Rex® Grant. March Biosciences' G-Rex® Grant will be used to advance the manufacturing of...
read more
PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto Co., Inc.
read more
CN Bio, a provider of organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, announced the establishment of a strategic partnership with Pharmaron, an R&D service provider for the life sciences industry.
read more
Kindeva announced the appointment of Melanie Cerullo as Chief Quality Officer to drive its quality, compliance and regulatory strategy.
read more
Wednesday, April 23, 2025
Tanner Pharma Group has announced the opening of its new US operations facility in Charlotte, NC. This purpose-built, 22,000+ square foot facility represents a significant investment in enhancing the company’s secondary packaging, labeling, storage ...
read more
SCIENTURE HOLDINGS announced the initiation of supply chain activities by its wholly owned subsidiary Scienture, LLC to manufacture launch quantities of Arbli™ (losartan potassium) Oral Suspension, 10 mg/mL for the intended commercial launch of the ...
read more
1ST Biotherapeutics, Inc. and LigaChem Biosciences have entered into a strategic partnership and licensing option agreement to co-develop novel payloads for antibody-drug conjugates (ADCs) as well as small molecule immuno-oncology therapies.
read more
CARBOGEN AMCIS announced that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).
The NMPA approval followed a rigorous review focused on GMP ...
read more
Phlow Corp. announced a significant expansion in its analytical capabilities, use of artificial intelligence (AI), workforce, and domestic infrastructure.
read more
ViroCell Biologics announced the opening of a University College London clinical trial to advance Professor Persis Amrolia’s innovative chimeric antigen receptor (CAR) T-cell therapy for relapsed pediatric acute lymphoblastic leukemia (ALL). Dr. ...
read more
Thermo Fisher Scientific announced the opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, Calif. This advanced facility is designed to accelerate the development and commercialization of cell therapies, specifically by ...
read more
CluePoints has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.
read more
Sirio Pharma announced the appointment of Mark Dewis as General Manager of the Sirio Americas Business Unit. Dr. Dewis brings more than 30 years of experience in the food, beverage, and nutritional supplement industries.
read more